MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$10,880K
Net Income
-$11,337K
Net Profit Margin
-104.20%
EPS
-$0.38
Unit: Thousand (K) dollars
Revenue Breakdown
Product
Service
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
10,880
12,128
10,410
8,861
Cost of revenue
4,170
4,372
4,006
3,261
Gross profit
6,710
7,756
6,404
5,600
Research and development costs
4,632
4,522
3,237
3,452
Sales and marketing expenses
6,768
6,715
4,770
3,838
General and administrative expenses
5,554
4,997
5,442
3,586
Operating loss
-10,244
-8,478
-7,045
-5,276
Other expense, net
-7
-35
-34
-64
Interest income
289
351
303*
-
Interest (expense) income, net
-
-
-
-543
Interest expense
1,413
1,382
1,006*
-
Net loss before income taxes
-11,375
-9,544
-7,782
-5,883
Income tax (benefit) expense
-38
8
4
8
Net loss
-11,337
-9,552
-7,786
-5,891
Basic EPS
-0.38
-0.32
-0.27
-0.21
Diluted EPS
-0.38
-0.32
-0.27
-0.21
Basic Average Shares
30,166,640
29,546,889
28,856,219
28,427,574
Diluted Average Shares
30,166,640
29,546,889
28,856,219
28,427,574
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$11,337K
(-94.23%↓ Y/Y)
Income tax (benefit)
expense
-$38K
(-252.00%↓ Y/Y)
Product
$7,376K
(22.99%↑ Y/Y)
Service
$3,504K
(8.89%↑ Y/Y)
Net loss before
income taxes
-$11,375K
(-95.72%↓ Y/Y)
Interest income
$289K
Total revenue
$10,880K
(18.07%↑ Y/Y)
Operating loss
-$10,244K
(-80.35%↓ Y/Y)
Interest expense
$1,413K
Gross profit
$6,710K
(20.77%↑ Y/Y)
Other expense, net
-$7K
(86.54%↑ Y/Y)
Cost of revenue
$4,170K
(13.97%↑ Y/Y)
Sales and marketing
expenses
$6,768K
(68.40%↑ Y/Y)
General and
administrative expenses
$5,554K
(63.93%↑ Y/Y)
Research and development
costs
$4,632K
(20.97%↑ Y/Y)
Buy us a coffee
ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. (CLPT)